Transgelin overexpression in lung adenocarcinoma is associated with tumor progression

Wu,Xiaohong; Dong,Liangliang; Zhang,Ruifeng; Ying,Kejing; Shen,Huahao

doi:10.3892/ijmm.2014.1805

Transgelin overexpression in lung adenocarcinoma is associated with tumor progression

Authors:
- Xiaohong Wu
- Liangliang Dong
- Ruifeng Zhang
- Kejing Ying
- Huahao Shen
View Affiliations

Affiliations: Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China, Department of Respiratory Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China
Published online on: June 16, 2014 https://doi.org/10.3892/ijmm.2014.1805
Pages: 585-591

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia is a common feature of solid tumors and is associated with an increased likelihood of local recurrence and distant metastasis. Transgelin (TAGLN) is an actin cross-linking/polymerization protein that belongs to the family of actin-associated proteins, and there is evidence that TAGLN may be involved in the migration of epithelial cells by interacting with actin or promoting podosome formation. Cell migration is a key step of cancer metastatis. Thus, the aim of this study was to investigate the potential link between TAGLN protein levels and hypoxia in lung adenocarcinoma cells and to explore the possible functions and expression patterns of TAGLN in lung adenocarcinoma. We first examined the effects of altered TAGLN expression on cell migration under both normoxic and hypoxic conditions. Immunohistochemical (IHC) staining was also performed to examine TAGLN protein expression patterns in lung adenocarcinoma samples. Our results revealed that TAGLN was upregulated in the hypoxic lung adenocarcinoma cells. The inhibition of TAGLN expression in the cells using small interfering RNA (siRNA) led to a decreased migration ability. TAGLN was significantly overexpressed in the lung adenocarcinoma tissues compared to the adjacent tumor-free tissues. A high TAGLN expression correlated with an advanced TNM stage, lymph node metastasis and greater differentiation. TAGLN was upregulated in the human lung adenocarcinoma cell lines under hypoxic conditions, which contributed to the migration ability of the cells. Thus, our data suggest that TAGLN may be a viable therapeutic target and a potential biomarker for predicting the prognosis of patients with lung adenocarcinoma.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Silvestri GA, Alberg AJ and Ravenel J: The changing epidemiology of lung cancer with a focus on screening. BMJ. 339:b30532009. View Article : Google Scholar : PubMed/NCBI
3	Brahimi-Horn C and Pouysségur J: The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer. 93:E73–E80. 2006.PubMed/NCBI
4	Fraga A, Ribeiro R and Medeiros R: Tumor hypoxia: the role of HIF. Actas Urol Esp. 33:941–951. 2009.(In Spanish).
5	Cassavaugh J and Lounsbury KM: Hypoxia-mediated biological control. J Cell Biochem. 112:735–744. 2011. View Article : Google Scholar : PubMed/NCBI
6	DeClerck K and Elble RC: The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci. 15:213–225. 2010. View Article : Google Scholar : PubMed/NCBI
7	Wilson WR and Hay MP: Targeting hypoxia in cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar
8	Assinder SJ, Stanton JA and Prasad PD: Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
9	Lambrechts A, Van Troys M and Ampe C: The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol. 36:1890–1909. 2004. View Article : Google Scholar : PubMed/NCBI
10	Zhang R, Zhou L, Li Q, Liu J, Yao W and Wan H: Up-regulation of two actin-associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia. Am J Respir Cell Mol Biol. 41:467–475. 2009. View Article : Google Scholar : PubMed/NCBI
11	Huang Q, Chen W, Wang L, Lin W, Lin J and Lin X: Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol. 134:1219–1227. 2008. View Article : Google Scholar : PubMed/NCBI
12	Ryu JW, Kim HJ, Lee YS, et al: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci. 18:505–509. 2003. View Article : Google Scholar : PubMed/NCBI
13	Mikuriya K, Kuramitsu Y, Ryozawa S, et al: Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol. 30:849–855. 2007.
14	Arvelo F and Cotte C: Hypoxia in cancer malignity. Review. Invest Clin. 50:529–546. 2009.(In Spanish).
15	Subarsky P and Hill RP: The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis. 20:237–250. 2003. View Article : Google Scholar : PubMed/NCBI
16	Giatromanolaki A and Harris AL: Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res. 21:4317–4324. 2001.PubMed/NCBI
17	Shapland C, Hsuan JJ, Totty NF and Lawson D: Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein. J Cell Biol. 121:1065–1073. 1993. View Article : Google Scholar : PubMed/NCBI
18	Fu Y, Liu HW, Forsythe SM, et al: Mutagenesis analysis of human SM22: characterization of actin binding. J Appl Physiol. 89:1985–1990. 2000.PubMed/NCBI
19	Shanahan CM, Weissberg PL and Metcalfe JC: Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 73:193–204. 1993. View Article : Google Scholar : PubMed/NCBI
20	Yu H, Königshoff M, Jayachandran A, et al: Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 22:1778–1789. 2008. View Article : Google Scholar : PubMed/NCBI
21	Gimona M, Kaverina I, Resch GP, Vignal E and Burgstaller G: Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell. 14:2482–2491. 2003. View Article : Google Scholar : PubMed/NCBI
22	Yamaguchi H and Condeelis J: Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
23	Zhao L, Wang H, Deng YJ, Wang S, Liu C, Jin H and Ding YQ: Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod Pathol. 22:786–796. 2009.PubMed/NCBI
24	Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant’Agnese PA and Chang C: Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol. 21:343–358. 2007. View Article : Google Scholar : PubMed/NCBI
25	Shi YY, Wang HC, Yin YH, et al: Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. Br J Cancer. 92:929–934. 2005. View Article : Google Scholar : PubMed/NCBI
26	Zhou L, Zhang R, Zhang L, Sun Y, Yao W, Zhao A, Li J and Yuan Y: Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer. Cancer Sci. 104:4234302013. View Article : Google Scholar